Brighton, England - 10 April 2014 - Covaris, Inc. announced that its European subsidiary, Covaris Ltd, located in the United Kingdom, will commence operations on May 1, 2014. It will be managed locally by Dr. Adrian Palmer, who brings 15 years' experience in scientific, customer support and commercial roles acquired at Roche, Sirigen (a BD company) and Lab 21.
Covaris Ltd has sales, service, and application representatives throughout Europe providing support for recently launched application kits such as truXTRAC™ for FFPE DNA extraction and truChIP™ for Chromatin shearing. Covaris, known for its proprietary Adaptive Focused Acoustics™ (AFA) technology, will enhance delivery times by shipping consumables, including the new microTUBE LV™, which enables DNA fragmenting in volumes as low as 15µl, from its European distribution centre in Brighton, England.
Covaris Founder and CEO, Jim Laugharn adds: "As analytical technologies for the life sciences become more sophisticated, the need for precise, accurate, and high-quality sample preparation becomes a critical prerequisite. By establishing a local presence with Covaris Ltd, we will be better positioned to serve our European customers by providing direct product, application, and customer support services."
Covaris utilizes proprietary technologies including Adaptive Focused Acoustic (AFA) to enable advanced sample preparation and optimization of analytical results. Founded in 1998, Covaris is a privately held technology company headquartered in Woburn, Massachusetts, USA.
Source: Covaris, Inc.